Evaluation of the implant disease risk assessment (IDRA) tool: A retrospective study in patients with treated periodontitis and implant-supported fixed dental prostheses (FDPs).

De Ry, Siro P.; Roccuzzo, Andrea; Lang, Niklaus P.; Heitz-Mayfield, Lisa J.; Ramseier, Christoph A.; Sculean, Anton; Salvi, Giovanni E. (2021). Evaluation of the implant disease risk assessment (IDRA) tool: A retrospective study in patients with treated periodontitis and implant-supported fixed dental prostheses (FDPs). Clinical oral implants research, 32(11), pp. 1299-1307. Wiley 10.1111/clr.13828

Preview

Text Clinical_Oral_Implants_Res_-_2021_-_De_Ry_-_Evaluation_of_the_implant_disease_risk_assessment_IDRA_tool_A_retrospective.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (968kB) | Preview

AIM

To evaluate the Implant Disease Risk Assessment (IDRA) tool for the prediction of peri-implantitis in treated periodontitis patients with implant-supported fixed dental prostheses (FDPs) after at least 5 years of function.

MATERIAL AND METHODS

From the patient pool of implant patients enrolled in a regular supportive periodontal therapy programme (SPT) for at least 5 years, 239 patients were screened. Eighty patients met the inclusion criteria and underwent evaluation through the criteria of the IDRA tool. Areas under the curve (AUCs) for receiver operating characteristic (ROC) curves including 95% confidence intervals were estimated.

RESULTS

Seventy-nine patients (43 males and 36 females, 8 smokers), aged on average 59.0 years (range: 40-79 years) at baseline (i.e. FDP delivery) were analysed. The calculated IDRA-risk was in 34 patients (42.5%) a moderate risk, while 45 patients (56.3%) were considered at high IDRA-risk. One patient categorized at low IDRA-risk was excluded from the analysis. The AUC was 0.613 (95% CI: 0.464-0.762) if the IDRA-risk was associated with prevalence of peri-implantitis at the most recent follow-up. Peri-implantitis was diagnosed in 4 patients (12%) at moderate and in 12 patients (27%) at high IDRA-risk, respectively. The calculated odds ratio for developing peri-implantitis in patients with high IDRA-risk compared with patients with moderate IDRA-risk was 2.727 with no statistically significant difference between the two groups (95% CI: 0.793-9.376).

CONCLUSION

Within the limitations of the present retrospective study, the IDRA algorithm might represent a promising tool to assess patients at moderate or high risk of developing peri-implantitis.

Interest & Impact

Downloads

61 since deposited on 26 Jan 2022
51 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item